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Metastatic tumors to the heart usually involve right sided chambers. We report a rare case
of malignant phyllodes tumor of breast with metastatic involvement of left atrium
occurring through direct invasion from mediastinal micro-metastasis and presenting as a
left atrial mass causing arrhythmia.
Copyright ª 2014, Cardiological Society of India. All rights reserved.A 50-year-old lady presented to the casualty department, with
history of an episode of sudden onset New York Heart Asso-
ciation (NYHA) class IV dyspnea and transient palpitation,
occurring about 3 h prior to presentation and subsiding
spontaneously. Her Electrocardiogram done in a primary
hospital showed supra-ventricular tachycardia.
At presentation, she was asymptomatic, with unremark-
able physical examination. There was past history of excision
of right breast lump with axillary clearance for a malignant
mass a year ago, followed by radiation therapy. On echocar-
diography, a large LA mass was seen occupying almost whole
of the LA cavity, with probable attachment to a pulmonary
vein (Fig. 1A). The mass had no attachment to inter atrialiology, Yashoda Hospital
oo.in (A. Bhambhani).
2014, Cardiological Societseptum. The LA appendage was free of thrombus. The mass
was intermittently protruding through the mitral orifice.
Remaining echocardiographic assessment was unremarkable.
In view of recent history of resection of malignant breast
tumor, it was considered essential to rule out malignant na-
ture of the LAmass and also to look for local metastases in the
surrounding thoracic viscera before planning definitive
treatment. Hence, probabilities of LA myxoma, breast metas-
tasis or LA thrombus were considered and computed tomog-
raphy (CT) of thorax with contrast was advised to further
characterize the mass. CT scan was performed on dual source
dual energy 64-slice MDCT scanner before and after injection
of 75 ml non-ionic iodinated contrast. It revealed a large, S.P. Road, Secunderabad 500003, India. Tel.: þ91 9989027102.
y of India. All rights reserved.
Fig. 1 e A: Echocardiogram in parasternal long axis view showing large mass in left atrium (arrow heads); MV -mitral valve,
LV- left ventricle. B: 64-slice MDCT with contrast showing filling defect in left atrium. C: Surgical specimen excised from left
atrium. D: H&E stain sections of breast tumor showing features of malignant Phyllodes having components of spindle cells
(D1) as well as neoplastic chondrocytes with high mitotic activity (D2) (arrows). E: H&E stain sections from left atrial mass
(E1) & breast mass (E2) showing histo-morphologically similar spindle cell components indicating common origin for both
neoplasms. F: PET scan showing abnormal tracer activity involving soft tissue mass occupying entire left superior
pulmonary vein and partially entering adjacent atrial cavity (large arrow). Small arrow indicates focal abnormal tracer
activity in the anterior wall of ascending aorta suggesting malignant embolism. G: Tomographic scan one month after atrial
tumor resection revealed pulmonary nodule (arrow) gaining access into the adjacent pulmonary vein (arrow head). H:
Positron emission tomography after tumor excision e the Maximum Intensity Projection image showing increased
metabolic activity in left atrium, extending into left superior pulmonary vein (arrow), corresponding to residual malignant
atrial tumor. Metastatic activity in left axillary lymph node (arrow head) is also visible. The midline shows metabolically
active sternotomy scar suggestive of inflammation.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 2 4 1e2 4 3242(55  39  41 mm) hypo dense filling defect lying along
postero-lateral wall and roof of LA (Fig. 1B), extending from
left superior pulmonary vein. The diagnostic possibilities of
thrombus and metastatic tumor were considered. In view of
absence of metastatic nodules in lung parenchyma or inmediastinum, thrombus was considered more likely, but the
scan did not allow for clear differentiation between bland
thrombus and tumor tissue. Similar attenuation value for
thrombus and tumor on CT scan is a known pitfall during
tumor evaluation.1 In view of potential for systemic
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 2 4 1e2 4 3 243embolization and/or acute mitral valve obstruction, early
surgical resection was performed. Left atriotomy revealed a
large tumor mass attached to left superior pulmonary vein,
occupying LA chamber and partially protruding into left ven-
tricular inflow. Presence of patent foramen ovale was ruled
out intra-operatively, since, it could be a potential explanation
for the metastatic route from breast to left atrium without
involving right heart, as revealed in CT scan. The mass was
resected and sent for histopathological examination (Fig. 1C).
The post-operative recovery was uneventful. Meanwhile, her
previous pathological records were reviewed, which revealed
the following. A breast tumor measuring 3.5  3  3 cm in size
was resected a year ago with axillary clearance. The base of
themass and soft tissuemarginswere free of abnormal tissue.
All the resected lymph nodeswere free of tumor. On histologic
examination, the breast lump had features of malignant
phyllodes having components of spindle cells (Fig. 1D e 1) as
well as neoplastic chondrocytes with high mitotic activity
(Fig. 1De 2). Immunohistochemical profilewas negative for ER
(Estrogen receptor), PR (Progesterone receptor) and Her2eu.
The cardiac tumor revealed histomorphologic features of a
sarcoma (Fig. 1E e 1) with features very similar to that of the
spindle cell component of the breast mass (Fig. 1E e 2), indi-
cating common origin for both the tumors.
A subsequently performed whole body positron emission
tomography (PET) scan with F18 e fluorodeoxy glucose
revealed an area of abnormal tracer activity in a soft tissue
mass occupying entire left superior pulmonary vein and
encroaching into adjacent LA wall (Fig. 1F e large arrow). A
one month later performed PET scan showed a single pul-
monary nodule with abnormal tracer activity abutting the left
superior pulmonary vein, suggesting vein erosion and access
into cardiac chamber (Fig. 1G and H). It is noteworthy that this
nodule was not visualized in previous scan. There was no
other hypermetabolic lesion in rest of the lungs. Interestingly,
another focus of increased radiotracer activity was found in
ascending aorta suggesting tumor embolization (Fig. 1F e
small arrow). The whole right breast and right axilla were free
of malignant activity; however, two left axillary lymph nodes
revealed hypermetabolic lesions (Fig. 1H). In addition, there
was a small subcutaneous lesion in right anterior abdominal
wall (Fig. 1H).
Cystosarcoma phyllodes, is a rare, locally aggressive and
recurrent tumor accounting for approximately 1% of breast
tumors. While metastases to heart are uncommon, cardiac
involvement is known.2 The pathways of metastatic invasion
of heart in descending order of frequency are tumor emboli-
zation throughveins, hematogenous spread, lymphatic spread
and direct invasion.3 Although relatively rare, hematogenous
metastasis is associated with poor prognosis.4 Other rare pre-
sentations of this tumor are RVmetastasis causing pulmonary
embolism, RVOT obstruction5 or even cardiogenic shock.6
The present case is interesting for many reasons. First,
Cystosarcoma Phyllodes metastasizing to heart is a rare en-
tity. Secondly, the tumor presented as a substantially large
intracavitary cardiac mass causing decompensation and sig-
nificant immediate risk potential, without easily recognizableinvolvement of other anatomically related structures to
explain the route of metastasis. In this case the metastatic
lesions of lung andmediastinumwere too small to be detected
even by CT scan at the time of diagnosis of cardiac tumor and
could be detected only by increased metabolic activity on PET
scan. In all other cases reporting pulmonary vein invasion
from mediastinum, the primary tumor was large enough to
explain local invasion, before extending into the pulmonary
vein.7 Thirdly, although extension of metastases into the left
atrium by invasion of the pulmonary veins is well docu-
mented for primary pulmonary malignancies, this phenom-
enon is uncommon for lung or mediastinal metastatic
lesions.4
In our case, the probable route of metastases was hema-
togenous into the contra lateral axillary lymph nodes, lung
and mediastinal lymph nodes. From the latter, it invaded
directly through the left superior pulmonary vein. Malignant
phyllodes are known to metastasize by the hematogenous
route rather than lymphatic. This also explains the reason for
negative nodes on initial axillary dissection.
Cardiac metastases are rare but important cardiovascular
diagnoses. Their potentially lethal course and the possibility
of avoiding major complications with excision, make their
diagnosis consequential. Malignant tumors may reach heart
through atypical routes. Strategic strong index of suspicion
and thorough investigation of every case may avoid missing
the diagnosis.Conflicts of interest
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